Porton Pharma Soluti...
SZSE:300363
¥ 20,41
+ ¥0,91 (4,67%)
20,41 ¥
+¥0,91 (4,67%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥-0,50
Earnings Per Share
¥5,56
Revenue Per Share
23,33%
Gross Margin %
¥10,53 B
Market Cap
¥0,91 B
Long-Term Debt
Earnings Per Share
¥-0,50
Revenue Per Share
¥5,56
Gross Margin %
23,33%
Market Cap
¥10,53 B
Long-Term Debt
¥0,91 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share ¥-0,53 ¥0,49 ¥3,69 ¥0,97 ¥0,60 ¥0,35 ¥0,26 ¥0,25 ¥0,40 ¥0,27 ¥0,31 ¥0,28
Earnings Earnings ¥-287,36M ¥267,56M ¥2,01B ¥528,07M ¥325,65M ¥189,96M ¥141,12M ¥106,18M ¥162,11M ¥113,85M ¥126,71M ¥101,59M
RPS Revenue Per Share ¥5,56 ¥6,72 ¥12,88 ¥5,70 ¥3,82 ¥2,86 ¥2,18 ¥2,79 ¥3,27 ¥2,42 ¥2,42 ¥2,02
Revenue Revenue ¥3,01B ¥3,67B ¥7,03B ¥3,11B ¥2,07B ¥1,55B ¥1,18B ¥1,18B ¥1,33B ¥1,02B ¥987,26M ¥734,36M
OCF Operating Cash Flow ¥405,53M ¥629,06M ¥2,56B ¥480,17M ¥504,37M ¥351,37M ¥193,62M ¥289,46M ¥285,33M ¥112,31M ¥121,92M ¥114,05M
FCF Free Cash Flow ¥1,39B ¥0,00M ¥1,39B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin -7,44% 7,96% 31,46% 17,90% 17,70% 11,51% 9,45% 14,31% 17,52% 14,61% 15,78% 17,53%
GM % Gross Margin % 23,33% 39,19% 51,66% 40,64% 40,30% 35,45% 32,91% 36,20% 37,69% 32,06% 35,54% 38,10%
FCFS Free Cash Flow Per Share ¥-0,16 ¥-0,92 ¥2,57 ¥-0,55 ¥0,21 ¥0,33 ¥0,05 ¥0,31 ¥0,23 ¥-0,76 ¥-0,55 ¥-0,20
LT Debt Long-Term Debt ¥908,98M ¥1,07B ¥312,91M ¥24,00M ¥107,02M ¥241,74M ¥255,36M ¥422,23M ¥183,57M ¥309,84M ¥93,34M ¥33,05M
Sha. Stocks 542,18M 546,04M 546,03M 544,4M 542,75M 542,75M 542,75M 424,72M 405,27M 421,66M 408,75M 362,81M
×